Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age group

May 04, 2022

New Delhi [India], May 4 : Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct...

Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2-18 age group

May 19, 2021

New Delhi [India], May 19 : The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of...

Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt

May 18, 2021

New Delhi [India], May 18 : Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in...

Quash notification allowing phase 2/3 trials of Covaxin in 2-18 years age group: PIL in Delhi HC

May 18, 2021

New Delhi [India], May 18 : A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of...

Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in 2 to 18 age group

Jun 03, 2021

New Delhi [India], June 3 : A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the...

COVID vaccination for 18-44 age group begins in Telangana

Jul 02, 2021

Hyderabad (Telangana) [India], July 2 : The COVID-19 vaccination drive for age group 18-44 commenced in Telangana on Thursday (July 1), the Director of...